Drugs logo Adis International logo

Publisher: Adis International

Volume 60, Number 2, August 2000
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Articles

The Potential Role of Antisense Oligodeoxynucleotide Therapy for Cardiovascular Disease
pp. 239-248(10)
Authors: Phillips M.I.; Galli S.M.; Mehta J.L.

Reviews

Potential Novel Uses of Thalidomide: Focus on Palliative Care
pp. 273-292(20)
Authors: Peuckmann V.; Fisch M.; Bruera E.

A Review of the Long Term Effects of Thrombolytic Agents
pp. 293-305(13)
Authors: van Domburg R.T.; Boersma E.; Simoons M.L.

Articles

Esomeprazole
pp. 321-329(9)
Authors: Spencer C.M.; Faulds D.

Esomeprazole: A Viewpoint by Peter Katelaris
pp. 330-331(2)
Author: Katelaris P.

Esomeprazole: A Viewpoint by Tore Lind
pp. 330-331(2)
Author: Lind T.

Pioglitazone
pp. 333-343(11)
Authors: Gillies P.S.; Dunn C.J.

Pioglitazone: A Viewpoint by John R. Petrie
pp. 344-345(2)
Author: Petrie J.R.

Pioglitazone: A Viewpoint by Vivian A. Fonseca
pp. 344-345(2)
Author: Fonseca V.A.

Clopidogrel: A Review of its Use in the Prevention of Atherothrombosis
pp. 347-377(31)
Authors: Jarvis B.; Simpson K.

Raloxifene: A Review of its Use in Postmenopausal Osteoporosis
pp. 379-411(33)
Authors: Clemett D.; Spencer C.M.

Zaleplon: A Review of its Use in the Treatment of Insomnia
pp. 413-445(33)
Authors: Dooley M.; Plosker G.L.

Abacavir: A Review of its Clinical Potential in Patients with HIV Infection
pp. 447-479(33)
Authors: Hervey P.S.; Perry C.M.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A